-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cxvw/XZ2PvvIzQdO9ULF8KGxULu6vrZ819OZ2e+5bmlFSNCJEE021YBRyoSBqy9W 5oU0H2MLF+9YrcwjIZBC8w== 0000927016-00-001282.txt : 20000413 0000927016-00-001282.hdr.sgml : 20000413 ACCESSION NUMBER: 0000927016-00-001282 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20000410 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20000412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NMT MEDICAL INC CENTRAL INDEX KEY: 0001017259 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 954090463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-21001 FILM NUMBER: 599328 BUSINESS ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6177370930 MAIL ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: NITINOL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19960619 8-K 1 FORM 8K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 10, 2000 NMT Medical, Inc. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in charter) Delaware 000-21001 95-4090463 - -------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer diction of incorporation) File Number) Identification No.) 27 Wormwood Street, Boston, Massachusetts 02210 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (617) 737-0930 N/A - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events. ------------ On April 10, 2000, NMT Medical, Inc. (the "Company") issued a press release announcing the resignation, effective immediately, of Thomas M. Tully as Chief Executive Officer of the Company to pursue other business opportunities. Accordingly, Mr. Tully has also resigned as President and as a member of the Board of Directors of the Company. The full text of the Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. ------------------------------------------------------------------ (c) Exhibits Exhibit No. Description - ----------- ----------- 99.1 Press Release, dated April 10, 2000, announcing the resignation of Thomas M. Tully as Chief Executive Officer of NMT Medical, Inc. -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 12, 2000 NMT Medical, Inc. ----------------- (Registrant) By: /s/ William J. Knight ---------------------------------------------- Name: William J. Knight Title: Vice President-Finance and Administration, Chief Financial Officer -3- EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 99.1 Press Release, dated April 10, 2000, announcing the resignation of Thomas M. Tully as Chief Executive Officer of NMT Medical, Inc. EX-99.1 2 PRESS RELEASE DATED APRIL 10, 2000 Exhibit 99.1 NMT MEDICAL, INC. 27 Wormwood Street Boston, MA 02210-1625 (Nasdaq/NMS:NMTI) AT THE COMPANY AT THE FINANCIAL RELATIONS BOARD - -------------- -------------------------------- Bill Knight, CFO General Info: Paula Schwartz (617) 737-0930 Analyst Info: Brian Gill Media Info: Deanne Eagle (212) 661-8030 FOR IMMEDIATE RELEASE - --------------------- April 10, 2000 NMT MEDICAL NAMES C. LEONARD GORDON ACTING CHIEF EXECUTIVE OFFICER ------------------------------------------------------------------ BOSTON, MA, APRIL 10, 2000--NMT Medical, Inc. (Nasdaq/NMS:NMTI) today announced the resignation of Thomas M. Tully as Chief Executive Officer of NMT Medical, to pursue other business opportunities. C. Leonard Gordon, a co-founder, Board Member and former President and Chief Executive Officer of NMT Medical, has been named Acting President and Chief Executive Officer. Mr. Tully will continue to assist the Company during the transition period. Carl A. Schaad of Heidrick & Struggles in Boston has been retained to conduct the search for a new Chief Executive Officer. Commenting on the announcement Mr. Gordon said, "We hope to complete the CEO search in the next few months. Until then, I intend to put particular emphasis on the sales and marketing of cardiovascular products. The closing last week of the sale of certain product lines in the Neurosciences division was an important step in the refocusing of the Company. Our focus is on high margin medical implantable products, disposables, reducing overall expenses, and on preserving the Company's innovative R&D culture." Dr. Jeffrey R. Jay, Chairman of NMT Medical said "We thank Tom for his efforts on behalf of the Company and wish him well." Commenting on the Company's progress, he noted "Growth in sales of CardioSeal(R) and the Simon Nitinol vena cava filters have driven cardiovascular revenue in Q1 2000 approximately 50% higher than Q1 1999. Record high unit sales of CardioSeal and Simon Nitinol Filters were achieved in Q1." --MORE-- NMT MEDICAL ANNOUNCES RESIGNATION OF CEO PAGE TWO NMT Medical designs, develops and markets innovative medical devices that utilize advanced design and materials and are delivered by minimally invasive procedures. The Company's products offer alternative approaches to existing more invasive treatments, thereby reducing patient trauma, shortening procedure, hospitalization and recovery times, and lowering overall treatment costs. The Company's medical devices include self-expanding stents, vena cava filters and septal repair devices. The NMT Neurosciences division serves the need of neurosurgeons with a focused set of products including cerebral spinal fluid shunts external drainage products and the Spetzler(TM) Titanium Aneurysm Clip. This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed under the heading "Certain Factors That May Affect Future Results" included in the Management's Discussion and Analysis of Financial Conditions and Results of Operations in the Company's Annual Report on Form 10-K for the Year ended December 31, 1998. To receive NMT Medical's latest news release and other corporate documents via FAX--at no cost--please dial 1-800-PRO-INFO. -----END PRIVACY-ENHANCED MESSAGE-----